GlassScriptPhysician profile
Ashley C Lowe
NPI 1770024093
$18,539.83
in general payments reported to CMS, 2019-2025
37 companies · $9,072 in 2025
The $9,072 reported for 2025 was more than what 99% of Primary Care providers received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $66.43 · 2023: $3,861 · 2024: $5,541 · 2025: $9,072.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Consulting Fee: $3,680 · Travel and Lodging: $2,265 · Education: $467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,061.50 |
| Consulting Fee | $3,680.00 |
| Travel and Lodging | $2,264.94 |
| Education | $466.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $6,335.39 | 2023-2025 | |
| Janssen Biotech, INC. | $2,155.54 | 2023-2025 | Erleada, Akeega, Rybrevant |
| Dendreon Pharmaceuticals LLC | $1,876.68 | 2023-2025 | Provenge |
| Axonics, INC. | $1,837.73 | 2023-2024 | Axonics |
| Astellas Pharma US INC | $669.99 | 2024-2025 | Xtandi, Padcev |
| Sun Pharmaceutical Industries INC. | $442.58 | 2024-2025 | |
| Myriad Genetic Laboratories, INC. | $432.62 | 2023-2025 | Prolaris, Myrisk |
| Sumitomo Pharma America, INC. | $420.91 | 2023-2025 | Orgovyx, Gemtesa |
| Pfizer INC. | $417.62 | 2023-2025 | |
| Blue Earth Diagnostics | $376.61 | 2024-2025 | Posluma |
| Procept Biorobotics Corporation | $346.71 | 2024 | Aquabeam System |
| Progenics Pharmaceuticals, INC. | $339.28 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $309.73 | 2023-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Astrazeneca Pharmaceuticals LP | $270.10 | 2022-2025 | Lynparza |
| Urogen Pharma, INC. | $228.16 | 2023-2025 | Jelmyto |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edap Technomed INC | $222.00 | 2024 | |
| Abbvie INC. | $220.04 | 2023-2025 | |
| Teleflex LLC | $203.14 | 2023 | Urolift |
| Endo Pharmaceuticals INC. | $163.71 | 2023 | Xiaflex |
| Novartis Pharmaceuticals Corporation | $146.24 | 2024-2025 | |
| Janssen Scientific Affairs, LLC | $142.93 | 2023 | Erleada |
| Accord Healthcare, INC. | $142.66 | 2024-2025 | |
| Immunitybio, INC. | $123.44 | 2024-2025 | |
| Verity Pharmaceuticals INC. | $100.28 | 2023-2025 | Trelstar |
| Convatec INC. | $91.11 | 2022-2023 | |
| Boston Scientific Corporation | $89.17 | 2025 | Axonics |
| Antares Pharma, INC. | $77.21 | 2023-2024 | Xyosted, Tlando, Nocdurna |
| Srs Medical Systems, INC. | $62.95 | 2025 | Ct3000 Pro Base Unit, Urocuff-Dc Disposable, Single |
| 180 Medical, INC. | $51.11 | 2023 | Gentlecath Glide |
| Caris Mpi, INC. | $48.06 | 2025 | Mi Cancer Seek |
| Foundation Medicine, INC. | $43.63 | 2023 | |
| Telix Pharmaceuticals | $30.30 | 2024 | Illuccix |
| Tempus Ai, INC | $28.61 | 2025 | Xt Cdx |
| Angiodynamics, INC. | $28.26 | 2023 | Nanoknife |
| Koelis INC. | $26.21 | 2024 | |
| Abc Home Medical Supply, INC. | $20.61 | 2022 | |
| Halozyme INC | $18.51 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Lowe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.